- Home
- ACTU vs RGC Comparison
ACTU vs RGC Comparison
Compare ACTU & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- RGC
- Stock Information
- Founded
- ACTU 2015
- RGC 2014
- Country
- ACTU United States
- RGC Hong Kong
- Employees
- ACTU N/A
- RGC N/A
- Industry
- ACTU
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ACTU
- RGC Health Care
- Exchange
- ACTU NYSE
- RGC Nasdaq
- Market Cap
- ACTU 153.1M
- RGC 171.1M
- IPO Year
- ACTU 2024
- RGC 2021
- Fundamental
- Price
- ACTU $8.06
- RGC $6.52
- Analyst Decision
- ACTU
- RGC
- Analyst Count
- ACTU 0
- RGC 0
- Target Price
- ACTU N/A
- RGC N/A
- AVG Volume (30 Days)
- ACTU 38.3K
- RGC 25.8K
- Earning Date
- ACTU 01-01-0001
- RGC 10-25-2024
- Dividend Yield
- ACTU N/A
- RGC N/A
- EPS Growth
- ACTU N/A
- RGC N/A
- EPS
- ACTU N/A
- RGC N/A
- Revenue
- ACTU N/A
- RGC N/A
- Revenue This Year
- ACTU N/A
- RGC N/A
- Revenue Next Year
- ACTU N/A
- RGC N/A
- P/E Ratio
- ACTU N/A
- RGC N/A
- Revenue Growth
- ACTU N/A
- RGC N/A
- 52 Week Low
- ACTU $7.33
- RGC $3.03
- 52 Week High
- ACTU $10.16
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- RGC 46.56
- Support Level
- ACTU N/A
- RGC $5.05
- Resistance Level
- ACTU N/A
- RGC $7.24
- Average True Range (ATR)
- ACTU 0.00
- RGC 0.78
- MACD
- ACTU 0.00
- RGC -0.03
- Stochastic Oscillator
- ACTU 0.00
- RGC 50.52
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.